Franklin Resources’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Franklin Resources’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-180,631	Closed	-$305K	–	2414
2022 Q4	$305K	Hold	180,631	–	–	﹤0.01%	1865
2022 Q3	$334K	Hold	180,631	–	–	﹤0.01%	1811
2022 Q2	$555K	Sell	180,631 -219,369	-55%	-$1.34M	﹤0.01%	1686
2022 Q1	$2.89M	Hold	400,000	–	–	﹤0.01%	1303
2021 Q4	$6.55M	Hold	400,000	–	–	﹤0.01%	1161
2021 Q3	$3.98M	Hold	400,000	–	–	﹤0.01%	1254
2021 Q2	$4M	Hold	400,000	–	–	﹤0.01%	1189
2021 Q1	$3.98M	Buy	+400,000	New	+$4.14M	﹤0.01%	1166

Other funds holding PRDS

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Franklin Resources's PRDS Position: Q1 2023 in Review

Franklin Resources sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q1 2023, closing a stake of 180,631 shares — an estimated $305K sold.

Franklin Resources first reported a position in PRDS in Q1 2021 and held it in 8 quarters. The position peaked at $6.55M in Q4 2021. 61 funds tracked by Wall St. Rank hold PRDS as of Q1 2023.

Franklin Resources reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Franklin Resources sold 180,631 Pardes Biosciences, Inc. Common Stock shares in Q1 2023, an estimated $305K.
Franklin Resources first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Franklin Resources's Pardes Biosciences, Inc. Common Stock position peaked at $6.55M in Q4 2021.
61 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.